1. Home
  2. CIVB vs ATYR Comparison

CIVB vs ATYR Comparison

Compare CIVB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVB
  • ATYR
  • Stock Information
  • Founded
  • CIVB 1884
  • ATYR 2005
  • Country
  • CIVB United States
  • ATYR United States
  • Employees
  • CIVB N/A
  • ATYR N/A
  • Industry
  • CIVB Major Banks
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CIVB Finance
  • ATYR Health Care
  • Exchange
  • CIVB Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • CIVB 349.3M
  • ATYR 290.6M
  • IPO Year
  • CIVB N/A
  • ATYR 2015
  • Fundamental
  • Price
  • CIVB $23.25
  • ATYR $3.21
  • Analyst Decision
  • CIVB Buy
  • ATYR Strong Buy
  • Analyst Count
  • CIVB 4
  • ATYR 6
  • Target Price
  • CIVB $25.67
  • ATYR $18.60
  • AVG Volume (30 Days)
  • CIVB 39.9K
  • ATYR 1.1M
  • Earning Date
  • CIVB 04-24-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • CIVB 2.94%
  • ATYR N/A
  • EPS Growth
  • CIVB N/A
  • ATYR N/A
  • EPS
  • CIVB 2.26
  • ATYR N/A
  • Revenue
  • CIVB $153,524,000.00
  • ATYR N/A
  • Revenue This Year
  • CIVB $17.44
  • ATYR $551.06
  • Revenue Next Year
  • CIVB $5.37
  • ATYR $2,144.84
  • P/E Ratio
  • CIVB $10.25
  • ATYR N/A
  • Revenue Growth
  • CIVB 2.34
  • ATYR N/A
  • 52 Week Low
  • CIVB $13.60
  • ATYR $1.42
  • 52 Week High
  • CIVB $23.70
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • CIVB 62.68
  • ATYR 49.79
  • Support Level
  • CIVB $21.58
  • ATYR $3.07
  • Resistance Level
  • CIVB $23.53
  • ATYR $3.47
  • Average True Range (ATR)
  • CIVB 0.93
  • ATYR 0.24
  • MACD
  • CIVB 0.06
  • ATYR -0.01
  • Stochastic Oscillator
  • CIVB 76.84
  • ATYR 37.16

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: